Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
2017 · Leukemia · 320 citations
https://doi.org/10.1038/leu.2017.253
A
Astghik Voskanyan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
88
Papers
607
Citations
8
h-index
7
i10-index
Astghik Voskanyan is an academic researcher. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment. The author has an h-index of 8, co-authored 75 publications.
ORCID: 0000-0002-6949-506XPapers by this author
worksHigh-risk additional chromosomal abnormalities at low blast counts herald death by CML
2020 · Leukemia · 86 citations
https://doi.org/10.1038/s41375-020-0826-9
ALL-544 Diagnosis and Treatment of Ph+ Acute Lymphoblastic Leukemia in Armenia: A Comprehensive Analysis From 2012 to 2023
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01121-2
ALL-620 Spectrum of Bacteria Isolated From Blood Cultures of Patients With Leukemia in Armenia
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01125-x
CML-143 Treatment Free Remission in CML in Lower Resource Setting: A Single-Center Experience
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01300-4
CLL-389 Dual Oncologic Challenges: Managing Chronic Lymphocytic Leukemia With Concurrent Melanoma and Breast Cancer: A Case Report
2024 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(24)01276-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat